In this article, published in the autumn 2012 issue of Innovations in Pharmaceutical Technology, Rob Scoffin (Cresset’s CEO) explores the chemical space around existing drug molecules to provide a lower-risk, lower-cost strategy for the discovery of new chemical entities.

Click below to read full article.